Prostate cancer relapse treatment could be cut from 35 visits to just five. See how new radiation technology may change your ...
Morning Overview on MSN
Capivasertib won FDA approval for a hard-to-treat form of prostate cancer
Men diagnosed with metastatic prostate cancer that lacks the PTEN protein now have a targeted drug option for the first time.
These can all be symptoms of benign prostatic hyperplasia (BPH), also known as an enlarged prostate. While BPH is common as ...
Prostate enlargement is a common age-related condition affecting millions of men. Learn about its symptoms, risk factors, ...
Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the ...
CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, announced today the integration of the ...
Thousands of men with prostate cancer will be offered a more targeted radiotherapy by the NHS which requires just five doses.
GREENBRAE, Calif.--(BUSINESS WIRE)--MarinHealth Medical Center (MHMC) announced today that its surgeons have performed the first Aquablation procedures to treat benign prostatic hyperplasia (BPH).
A urologist at the Fox Chase-Temple Urologic Institute explains the options and warns that ignoring an enlarged prostate ...
As men get older, it’s common to notice changes when going to the bathroom. If you feel like you can’t fully empty your bladder, you have a weak urine stream, or you’re waking up often at night to use ...
Drug therapy for BPH can be categorized into two groups: agents that interfere with testosterone's stimulatory effect on prostate enlargement and agents that relax prostatic smooth muscle. Of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results